Replies to post #7322 on Halozyme Therapeutics Inc (HALO)

[maumar]

I am not familiar with CFRA research but imho this type of analysis is useless for a company like Halo.

Given that the XBI was up over 2% and many biotechs were very strong, stock action was somewhat concerning today, and volume was pretty high. We tend to do better on risk off days, though.

I think we are right at the 50 day moving average. Hopefully, the stock bounces from here.